Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Epigenetics|August 21, 2013
Considerations for normalization of DNA methylation data by Illumina 450K BeadChip assay in population studiesPaul Yousefi, Karen Huen, Raul Aguilar Schall, et al.
Plos One|July 21, 2015
Genome-Wide Assessment of Differential DNA Methylation Associated with Autoantibody Production in Systemic Lupus ErythematosusSharon A Chung, Joanne Nititham, Emon Elboudwarej, et al.
Plos One|April 15, 2025
Trop-2 expression in non-small cell lung cancerPeiwen Kuo, Emon Elboudwarej, Marianna Zavodovskaya, et al.
Plos One|October 26, 2023
RNA-seq RNAaccess identified as the preferred method for gene expression analysis of low quality FFPE samplesKai Song, Emon Elboudwarej, Xi Zhao, et al.
Rheumatology and Therapy|July 25, 2023
Filgotinib Modulates Inflammation-Associated Peripheral Blood Protein Biomarkers in Adults with Active Rheumatoid Arthritis and Prior Inadequate Response to MethotrexateYoshiya Tanaka, Peter C Taylor, Emon Elboudwarej, et al.
Plos One|March 4, 2015
Genome-wide DNA methylation profiles indicate CD8+ T cell hypermethylation in multiple sclerosisSteffan D Bos, Christian M Page, Bettina K Andreassen, et al.
Journal of Autoimmunity|January 20, 2016
Hypomethylation within gene promoter regions and type 1 diabetes in discordant monozygotic twinsEmon Elboudwarej, Michael Cole, Farren B S Briggs, et al.
Histopathology|January 10, 2024
Associations of TACSTD2/TROP2 and NECTIN-4/NECTIN-4 with molecular subtypes, PD-L1 expression, and FGFR3 mutational status in two advanced urothelial bladder cancer cohortsVeronika Bahlinger, Annalena Branz, Pamela L Strissel, et al.
Infectious Diseases and Therapy|April 19, 2023
Consistent Effects of Early Remdesivir on Symptoms and Disease Progression Across At-Risk Outpatient Subgroups: Treatment Effect Heterogeneity in PINETREE StudySamuel M Brown, Morgan J Katz, Adit A Ginde, et al.
Journal for Immunotherapy of Cancer|December 11, 2021
Randomized, open-label, phase 2 study of andecaliximab plus nivolumab versus nivolumab alone in advanced gastric cancer identifies biomarkers associated with survivalManish A Shah, David Cunningham, Jean-Philippe Metges, et al.
Pageof 2